Developing Best-in-class HDAC6 Inhibitors for the Treatment of CMT1A Play video: Developing Best-in-class HDAC6 Inhibitors for the Treatment of CMT1ATechnicalFriday, Sept 27 · Researcher DayFrederik Rombouts · Augustine TherapeuticsBack to all sessions
